
Apogee Therapeutics, Inc.
USD132.68
+0.07 (+0.05%)
CEO
Michael Thomas Henderson
IPO Date
2023-07-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$132.72
Prev. Close
$132.61
Day Low
$132.65
Day High
$132.83
52W Low
$34.34
52W High
$133.16
Market Cap
$8.19B
Volume
2.81M
| Mizuho |
| Outperform |
| Neutral |
| downgrade |
| 23 Jun 2026 | Deutsche Bank | Buy | Hold | downgrade |
| 23 Jun 2026 | Citigroup | Buy | Neutral | downgrade |
| 23 Jun 2026 | Wedbush | Outperform | Neutral | downgrade |
| 23 Jun 2026 | UBS | Buy | Neutral | downgrade |
| 23 Jun 2026 | RBC Capital | Sector Perform | Sector Perform | maintain |
| 22 Jun 2026 | Canaccord Genuity | Buy | Hold | downgrade |